China Sky One Medical Obtains SFDA Approval For Two New Drugs
October 31, 2008 | By Editor |
Print This Page
| 
Email This Page
Harbin based China Sky One Medical, a pharmaceutical company producing over-the-counter drugs in the China recently obtained production approval from the Chinese State Food and Drug Administration for two of its newly developed drugs.
Sodium Ferulate by injection is intended for the treatment of cardiovascular disease. It works by inhibiting the gathering of hematoblasts and stretches blood vessels in order to protect cardiac muscles. Doxofylline by injection is intended for the treatment of asthma and bronchitis. It works on bronchia and relaxes bronchial smooth muscle in order to restrain asthma.
(No Ratings Yet)
Loading ...
